Welcure Drugs and Pharmaceuticals Ltd.BSE: WELCURE

Statement Of Deviation Variation Under Regulation 32 Of SEBI (LODR)Regulation 2015

· Issued by Welcure Drugs and Pharmaceuticals Ltd. via BSE India

Filed with BSE · · 4 pages · English

Submitted for your information and records. SURAJ CHAGAN SOLANKI DIRECTOR DIN- 10380845 Name of listed entity Welcure Drugs & Pharmaceuticals Limited Mode of Fund Raising Preferential Issue Date of Raising Funds July 18, 2024 ( Date of Allotment) Amount Raised On Allotment of 9,90,00,000 Fully Convertible Warrants Rs. 24,75,00,000/- On Conversion of 3,29,99,997 Warrants into equal number of equi

Welcure Drugs and Pharmaceuticals Ltd. on 6ix

Earlier from Welcure Drugs and Pharmaceuticals

Later from Welcure Drugs and Pharmaceuticals

All Welcure Drugs and Pharmaceuticals news releases